Cost/Benefit

Revenue implications

• A median-sized Kidney transplant program collects $1.5-3M in contributions/year (mix of CMS & private-pay insurers)
• A median-sized Liver transplant program collects $2.5-5M
• Even temporary sanctions can stop this flow of contribution to the parent organization
• Gaining/losing a single transplant patient from a CoE can mean a gain (or loss) of $75,000 or more

Regulatory risks

• The costs of complying with a Service Improvement Agreement (SIA) can exceed $2 million in direct compliance costs

Missed opportunities & extra costs

• The overall cost for transplanting a patient whose medical condition deteriorated significantly while on the wait list can exceed four times the original cost
• Transplanting a patient whose insurance has changed or lapsed may require the center to absorb $100,000 or more in cost

Alternatives

• ‘Do it yourself’ and run the risk of inaccurate assessment of center performance and regulatory scrutiny
• Hire an in-house PhD-level biostatistician with expertise in transplantation. Difficult to find, transplant biostatisticians’ average salaries can exceed $200K per year

XynQAPI is a cost-efficient solution with a high return

• 100% of XynManagement tools and services are considered pre-transplant care and can therefore be included on the Medicare Cost Recovery Report.  Depending on your mix of Medicare payment, 50% or more of the annual XynMangement costs can be reimbursed
• XynQAPI software tools and economical wait list management services free up your time-constrained, highly-trained and valuable staff members to focus on patient care
• Your net annual investment in XynManagement tools & services equates to roughly the value received for 2 procedures and is a fraction of the cost and lost revenue sustained under CMS sanctions and an SIA